Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,71 USD | +1,18% | -13,64% | -41,64% |
11/04 | CARISMA THERAPEUTICS, INC. : BTIG is positief over | ZM |
02/04 | CARISMA THERAPEUTICS, INC. : HC Wainwright herhaalt koopadvies voor het aandeel | ZM |
Omzet 2024 * | 16,93 mln. 15,9 mln. | Omzet 2025 * | 13,83 mln. 12,99 mln. | Marktkapitalisatie | 71,04 mln. 66,71 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -58 mln. -54,47 mln. | Nettowinst (verlies) 2025 * | -69 mln. -64,8 mln. | EV/omzet 2024 * | 4,2 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 5,14 x |
K/w-verhouding 2024 * |
-1,33
x | K/w-verhouding 2025 * |
-1,28
x | Werknemers | 107 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 67,27% |
1 dag | +1,18% | ||
1 week | -13,64% | ||
Lopende maand | -24,67% | ||
1 maand | -24,67% | ||
3 maanden | -27,23% | ||
6 maanden | -44,66% | ||
Lopend jaar | -41,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 34 | 01-01-16 | |
Steven Kelly
CEO | Chief Executive Officer | 59 | 01-02-18 |
Richard Morris
DFI | Director of Finance/CFO | 51 | 01-06-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Kelly
CEO | Chief Executive Officer | 59 | 01-02-18 |
Sanford Zweifach
CHM | Chairman | 68 | 01-11-21 |
Director/Board Member | 66 | 01-02-22 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.00% | 34 M€ | +1,04% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 1,71 | +1,18% | 174 528 |
17-04-24 | 1,69 | -0,59% | 215 000 |
16-04-24 | 1,7 | -3,41% | 194 033 |
15-04-24 | 1,76 | -8,81% | 190 599 |
12-04-24 | 1,93 | -2,53% | 217 650 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-41,64% | 71,04 mln. | |
-3,30% | 102 mld. | |
+1,79% | 96,07 mld. | |
-1,16% | 21,66 mld. | |
-18,35% | 20,77 mld. | |
-8,28% | 18,53 mld. | |
-40,31% | 16,91 mld. | |
-26,84% | 13,79 mld. | |
+0,59% | 13,33 mld. | |
+20,86% | 10,94 mld. |